Tower Research Capital (TRC)’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-8,120
| Closed | -$144K | – | 4730 |
|
|
2018
Q3 | $144K | Buy |
8,120
+7,974
| +5,462% | +$141K | 0.01% | 1156 |
|
|
2018
Q2 | $2K | Sell |
146
-16,197
| -99% | -$222K | ﹤0.01% | 3432 |
|
|
2018
Q1 | $149K | Buy |
16,343
+15,433
| +1,696% | +$141K | 0.01% | 1031 |
|
|
2017
Q4 | $4K | Buy |
+910
| New | +$4K | ﹤0.01% | 3038 |
|
|
2017
Q3 | – | Sell |
-23,841
| Closed | -$36K | – | 4495 |
|
|
2017
Q2 | $36K | Buy |
+23,841
| New | +$36K | ﹤0.01% | 920 |
|
|
2017
Q1 | – | Sell |
-100
| Closed | – | – | 4411 |
|
|
2016
Q4 | $0 | Buy |
+100
| New | – | ﹤0.01% | 4768 |
|
|
2016
Q3 | – | Sell |
-4,466
| Closed | -$15K | – | 4979 |
|
|
2016
Q2 | $15K | Buy |
4,466
+2,810
| +170% | +$9.44K | ﹤0.01% | 2504 |
|
|
2016
Q1 | $5K | Buy |
1,656
+1,532
| +1,235% | +$4.63K | ﹤0.01% | 2801 |
|
|
2015
Q4 | $0 | Sell |
124
-9,014
| -99% | – | ﹤0.01% | 5430 |
|
|
2015
Q3 | $42K | Buy |
9,138
+2,520
| +38% | +$11.6K | ﹤0.01% | 1151 |
|
|
2015
Q2 | $35K | Buy |
+6,618
| New | +$35K | ﹤0.01% | 1647 |
|
|
2015
Q1 | – | Sell |
-1,155
| Closed | -$7K | – | 5241 |
|
|
2014
Q4 | $7K | Sell |
1,155
-2,948
| -72% | -$17.9K | ﹤0.01% | 2504 |
|
|
2014
Q3 | $25K | Buy |
4,103
+3,653
| +812% | +$22.3K | ﹤0.01% | 2131 |
|
|
2014
Q2 | $3K | Sell |
450
-2,209
| -83% | -$14.7K | ﹤0.01% | 3282 |
|
|
2014
Q1 | $64K | Buy |
2,659
+754
| +40% | +$18.1K | 0.01% | 921 |
|
|
2013
Q4 | $21K | Sell |
1,905
-2,112
| -53% | -$23.3K | ﹤0.01% | 2303 |
|
|
2013
Q3 | $54K | Buy |
+4,017
| New | +$54K | 0.01% | 1847 |
|